81,321 Shares in Sotera Health Company $SHC Bought by Man Group plc

Man Group plc acquired a new position in shares of Sotera Health Company (NASDAQ:SHC) during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 81,321 shares of the company’s stock, valued at approximately $1,443,000.

A number of other institutional investors also recently bought and sold shares of SHC. IFP Advisors Inc raised its holdings in shares of Sotera Health by 1,105.6% in the fourth quarter. IFP Advisors Inc now owns 1,495 shares of the company’s stock valued at $26,000 after buying an additional 1,371 shares during the last quarter. Rothschild Investment LLC acquired a new stake in shares of Sotera Health during the fourth quarter worth about $27,000. Meeder Asset Management Inc. purchased a new position in shares of Sotera Health during the second quarter worth about $37,000. Root Financial Partners LLC grew its holdings in shares of Sotera Health by 217.5% during the first quarter. Root Financial Partners LLC now owns 2,124 shares of the company’s stock worth $30,000 after buying an additional 1,455 shares during the last quarter. Finally, Eurizon Capital SGR S.p.A. acquired a new position in Sotera Health in the 4th quarter valued at about $40,000. 91.03% of the stock is currently owned by institutional investors and hedge funds.

Sotera Health Price Performance

Shares of NASDAQ:SHC opened at $18.96 on Thursday. The company has a quick ratio of 2.55, a current ratio of 2.80 and a debt-to-equity ratio of 3.33. The company has a market cap of $5.41 billion, a P/E ratio of 33.26 and a beta of 1.77. Sotera Health Company has a 52 week low of $13.09 and a 52 week high of $19.85. The company has a 50-day moving average price of $18.28 and a 200 day moving average price of $16.44.

Sotera Health (NASDAQ:SHC) last announced its quarterly earnings data on Thursday, August 6th. The company reported $0.26 earnings per share for the quarter, beating analysts’ consensus estimates of $0.24 by $0.02. The company had revenue of $321.38 million for the quarter, compared to analyst estimates of $309.70 million. Sotera Health had a return on equity of 40.12% and a net margin of 13.44%.The firm’s revenue for the quarter was up 9.2% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.20 EPS. Sotera Health has set its FY 2026 guidance at 0.950-1.010 EPS. Research analysts predict that Sotera Health Company will post 0.86 earnings per share for the current year.

Wall Street Analyst Weigh In

Several analysts have commented on SHC shares. Wall Street Zen raised Sotera Health from a “buy” rating to a “strong-buy” rating in a research note on Saturday, August 29th. The Goldman Sachs Group started coverage on Sotera Health in a report on Friday, June 5th. They issued a “buy” rating and a $20.00 target price on the stock. Weiss Ratings upgraded Sotera Health from a “hold (c)” rating to a “hold (c+)” rating in a research note on Tuesday, August 11th. JPMorgan Chase & Co. increased their price target on Sotera Health from $16.00 to $18.00 and gave the stock a “neutral” rating in a report on Friday, August 7th. Finally, UBS Group set a $19.00 price objective on shares of Sotera Health in a research report on Wednesday, June 24th. Eight research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $21.50.

Insider Buying and Selling

In other Sotera Health news, Chairman Michael B. Jr. Petras sold 850,000 shares of the stock in a transaction on Monday, August 17th. The stock was sold at an average price of $18.50, for a total value of $15,725,000.00. Following the completion of the transaction, the chairman owned 3,969,393 shares in the company, valued at approximately $73,433,770.50. This represents a 17.64% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Michael P. Rutz sold 150,000 shares of the firm’s stock in a transaction on Friday, August 7th. The shares were sold at an average price of $18.84, for a total value of $2,826,000.00. Following the completion of the sale, the insider directly owned 334,279 shares of the company’s stock, valued at approximately $6,297,816.36. This trade represents a 30.97% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders sold 1,294,515 shares of company stock worth $23,999,528. Company insiders own 15.36% of the company’s stock.

Sotera Health Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.